For participants who had alcohol use disorder, obesity and type 2 diabetes, the use of GLP-1 medications was linked to ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...